FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146447031> ?p ?o ?g. }

• W2146447031 endingPage "R644" @default.
• W2146447031 startingPage "R644" @default.
• W2146447031 abstract "The objective was to improve understanding of adverse events occurring with celecoxib in the treatment of osteoarthritis and rheumatoid arthritis. Data were extracted from company clinical trial reports of randomised trials of celecoxib in osteoarthritis or rheumatoid arthritis lasting 2 weeks or more. Outcomes were discontinuations (all cause, lack of efficacy, adverse event, gastrointestinal adverse event), endoscopically detected ulcers, gastrointestinal or cardio-renal events, and major changes in haematological parameters. The main comparisons were celecoxib (all doses) versus placebo, paracetamol (acetaminophen) 4,000 mg daily, rofecoxib 25 mg daily, or nonsteroidal anti-inflammatory drugs (NSAIDs) (naproxen, diclofenac, ibuprofen, and loxoprofen). For NSAIDs, celecoxib was compared both at all doses and at licensed doses (200 to 400 mg daily). Thirty-one trials included 39,605 randomised patients. Most patients had osteoarthritis and were women of average age 60 years or above. Most trials lasted 12 weeks or more. Doses of celecoxib were 50 to 800 mg/day. Compared with placebo, celecoxib had fewer discontinuations for any cause or for lack of efficacy, fewer serious adverse events, and less nausea. It had more patients with dyspepsia, diarrhoea, oedema, more adverse events that were gastrointestinal or treatment related, and more patients experiencing an adverse event. There were no differences for hypertension, gastrointestinal tolerability, or discontinuations for adverse events. Compared with paracetamol, celecoxib had fewer discontinuations for any cause, for lack of efficacy, or diarrhoea, but no other differences. Compared with rofecoxib, celecoxib had fewer patients with abdominal pain and oedema, but no other differences. Compared with NSAIDs, celecoxib had fewer symptomatic ulcers and bleeds, endoscopically detected ulcers, and discontinuations for adverse events or gastrointestinal adverse events. Fewer patients had any, or a gastrointestinal, or a treatment-related adverse event, or vomiting, abdominal pain, dyspepsia, or reduced haemoglobin or haematocrit. Discontinuations for lack of efficacy were higher. No differences were found for all-cause discontinuations, serious adverse events, hypertension, diarrhoea, nausea, oedema, myocardial infarction, cardiac failure, or raised creatinine. Company clinical trial reports present much more information than published papers. Adverse event information is clearly presented in company clinical trial reports, which are an ideal source of information for systematic review and meta-analysis." @default.
• W2146447031 created "2016-06-24" @default.
• W2146447031 creator A5029049881 @default.
• W2146447031 creator A5063980426 @default.
• W2146447031 creator A5077191679 @default.
• W2146447031 creator A5086186192 @default.
• W2146447031 date "2005-01-01" @default.
• W2146447031 modified "2023-10-16" @default.
• W2146447031 cites W147691740 @default.
• W2146447031 cites W1480729244 @default.
• W2146447031 cites W1548435580 @default.
• W2146447031 cites W1607015646 @default.
• W2146447031 cites W1967959895 @default.
• W2146447031 cites W1978759500 @default.
• W2146447031 cites W1986215651 @default.
• W2146447031 cites W1995534177 @default.
• W2146447031 cites W1998976537 @default.
• W2146447031 cites W1999502359 @default.
• W2146447031 cites W2000442546 @default.
• W2146447031 cites W2008127512 @default.
• W2146447031 cites W2020104085 @default.
• W2146447031 cites W2028950040 @default.
• W2146447031 cites W2038693293 @default.
• W2146447031 cites W204046373 @default.
• W2146447031 cites W2041221488 @default.
• W2146447031 cites W2044214724 @default.
• W2146447031 cites W2044750065 @default.
• W2146447031 cites W2048722122 @default.
• W2146447031 cites W2051699674 @default.
• W2146447031 cites W2052139512 @default.
• W2146447031 cites W2060913911 @default.
• W2146447031 cites W2077018765 @default.
• W2146447031 cites W2090362854 @default.
• W2146447031 cites W2093586224 @default.
• W2146447031 cites W2103637716 @default.
• W2146447031 cites W2111149452 @default.
• W2146447031 cites W2112554263 @default.
• W2146447031 cites W2115679325 @default.
• W2146447031 cites W2116446898 @default.
• W2146447031 cites W2118840514 @default.
• W2146447031 cites W2127937819 @default.
• W2146447031 cites W2135168058 @default.
• W2146447031 cites W2146330885 @default.
• W2146447031 cites W2153972688 @default.
• W2146447031 cites W2157651084 @default.
• W2146447031 cites W2160950772 @default.
• W2146447031 cites W2163756514 @default.
• W2146447031 cites W2165297900 @default.
• W2146447031 cites W2330496155 @default.
• W2146447031 cites W2396983484 @default.
• W2146447031 cites W2407874032 @default.
• W2146447031 cites W94442603 @default.
• W2146447031 cites W2595437246 @default.
• W2146447031 doi "https://doi.org/10.1186/ar1704" @default.
• W2146447031 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1526572" @default.
• W2146447031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15899051" @default.
• W2146447031 hasPublicationYear "2005" @default.
• W2146447031 type Work @default.
• W2146447031 sameAs 2146447031 @default.
• W2146447031 citedByCount "219" @default.
• W2146447031 countsByYear W21464470312012 @default.
• W2146447031 countsByYear W21464470312013 @default.
• W2146447031 countsByYear W21464470312014 @default.
• W2146447031 countsByYear W21464470312015 @default.
• W2146447031 countsByYear W21464470312016 @default.
• W2146447031 countsByYear W21464470312017 @default.
• W2146447031 countsByYear W21464470312018 @default.
• W2146447031 countsByYear W21464470312019 @default.
• W2146447031 countsByYear W21464470312020 @default.
• W2146447031 countsByYear W21464470312021 @default.
• W2146447031 countsByYear W21464470312022 @default.
• W2146447031 countsByYear W21464470312023 @default.
• W2146447031 crossrefType "journal-article" @default.
• W2146447031 hasAuthorship W2146447031A5029049881 @default.
• W2146447031 hasAuthorship W2146447031A5063980426 @default.
• W2146447031 hasAuthorship W2146447031A5077191679 @default.
• W2146447031 hasAuthorship W2146447031A5086186192 @default.
• W2146447031 hasBestOaLocation W21464470311 @default.
• W2146447031 hasConcept C126322002 @default.
• W2146447031 hasConcept C142724271 @default.
• W2146447031 hasConcept C181199279 @default.
• W2146447031 hasConcept C185592680 @default.
• W2146447031 hasConcept C197934379 @default.
• W2146447031 hasConcept C204787440 @default.
• W2146447031 hasConcept C27081682 @default.
• W2146447031 hasConcept C2776164576 @default.
• W2146447031 hasConcept C2776467144 @default.
• W2146447031 hasConcept C2777077863 @default.
• W2146447031 hasConcept C2777575956 @default.
• W2146447031 hasConcept C2778115740 @default.
• W2146447031 hasConcept C2778375690 @default.
• W2146447031 hasConcept C2778582115 @default.
• W2146447031 hasConcept C2778722691 @default.
• W2146447031 hasConcept C2779528491 @default.
• W2146447031 hasConcept C2779689624 @default.
• W2146447031 hasConcept C2779826273 @default.
• W2146447031 hasConcept C2779944601 @default.
• W2146447031 hasConcept C2780580376 @default.

• next